Skip to Content Facebook Feature Image

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Business

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid
Business

Business

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

2026-11-20 05:32 Last Updated At:05:55

Professor Theo Kofidis Brings Two Decades of Minimally Invasive Cardiac Surgery Experience to Mount Elizabeth, Orchard

SINGAPORE, Nov. 20, 2026 /PRNewswire/ -- In a significant recognition of his international standing, Professor Theo Kofidis has secured the bid for Singapore to host the World Society of Cardiovascular & Thoracic Surgeons (WSCTS) Annual Meeting in 2028 and will serve as President of the Society for that year.

More Images
Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

With more than 30 years' experience in cardiac surgery, the former NUHCS department Head offers the full spectrum of Open and Minimally Invasive Heart Surgery at Mount Elizabeth Medical Centre, Orchard.

Heart surgery is often associated with fear, major trauma, and restrictions during the convalescence phase. However, it doesn't have to be this way. Modern technology, specialised minimally invasive techniques, and advanced perioperative care protocols can transform the perception of- and early recovery after cardiac procedures.

A comprehensive minimally invasive programme—a specialized centre for less invasive heart surgery treatments founded upon two decades of experience—has now opened in Singapore.

Theo Kofidis Cardiac Surgery provides personalised heart surgery solutions across the entire modern spectrum of minimally invasive and conventional procedures. Patients receive state-of-the-art consultations at his brand-new clinic located at Mount Elizabeth Medical Centre, Orchard (#11-06). The clinic treats adults with all cardiac conditions, including heart valve and coronary artery disease.

The practice is led by cardiothoracic surgeon Professor Theodoros (Theo) Kofidis, whose clinical and academic career includes a number of highlights:

  • Served as the Head of Department and Group Chief of Cardiothoracic Surgery at the National University Heart Centre, Singapore (NUHCS) cluster hospitals
  • Specialises in minimally invasive and complex open procedures, having introduced a number of innovations and techniques with far-reaching impact
  • Trained numerous surgeons and clinical teams across the region, helping them establish their own modern heart surgery programmes
  • Established the National University Health System (NUHS) Minimally Invasive Heart Surgery programme, successfully popularising MICS in Singapore and beyond.
  • Conducted extensive laboratory and clinical research, developing innovative new tools for the field of MICS
  • Authored a comprehensive textbook on MICS, published by one of the world's oldest and largest publishing houses.
  • Fellow of the American Association for Thoracic Surgery (AATS), past Conference President of the ACVTS, Chair of Surgeon Education for the ACVTS, and incoming President of the World Society for Cardiovascular and Thoracic Surgery (WSCVTS) for 2028.
  • Recipient of numerous prestigious international awards for clinical excellence and research
  • Well-sought-after international speaker who has delivered lectures at the AMA, the Bill & Melinda Gates Foundation/Research initiatives, Grand Rounds, and premier surgical conferences worldwide.

UNDERSTANDING MINIMALLY INVASIVE CARDIAC SURGERY

Minimally invasive cardiac surgery (MICS) is an established approach used for a variety of cardiac procedures. Whereas conventional surgery commonly involves a median sternotomy, in which the breastbone is divided to provide access to the heart, minimally invasive procedures may use smaller incisions between the ribs or a limited incision through part of the breastbone.

The access route and operative technique depend on the procedure. A smaller incision does not necessarily mean that an operation is less complex or suitable for every patient.

However, the majority of conditions and patients can be treated in a minimally invasive manner by Professor Kofidis, building upon pioneering work and experience over the last two decades to provide refined, patient-centered surgical care.

CHOOSING THE SURGICAL APPROACH

Surgical options are considered following an individual clinical evaluation. This includes the patient's medical history, current condition, anatomy, and available investigation results. Echocardiography, CT imaging, or coronary assessments may be requested when clinically indicated.

For the majority of patients, minimally invasive techniques may be considered for heart valve surgery as well as selected cases of coronary artery disease, offering significant early advantages, such as:

  • Less trauma and burden to the body¹
  • Faster and easier mobility²
  • Less blood loss¹
  • Less infections²
  • Less arrhythmias³
  • Early lung function and respiratory recovery¹
  • Easier mobilisation and discharge from the hospital, hence facilitating an improved early postoperative experience for the patient, who can return to full functionality faster⁴

Conventional surgery may be more appropriate in other circumstances, including when the procedure is complex or there are anatomical or medical factors affecting the surgical approach.

"Our surgical team looks at your case from both a conventional and a minimally invasive perspective," says Professor Kofidis. The Platform of Care offered is not only based upon specialised surgical skill, but also fast-track treatments, perioperative conditioning of the patient, early awakening, extubating, and hospital discharge, as well as meticulous quality control—including surgical documentation and outcome measurements in the operating theatre. These comprise:

  • Photographic and video documentation of procedures for retention and information purposes⁵
  • Intraoperative and follow-up assessment of heart valve repairs by transesophageal echocardiography (TEE)⁶
  • Transit-time flow measurement of bypass grafts⁷

Together, these standards constitute a holistic and structured approach to high-quality surgical care.

RECOVERY AND FOLLOW-UP CARE

Recovery after cardiac surgery varies with the procedure, the patient's general health, and postoperative progress.

Perioperative planning may include preoperative optimisation, anaesthetic and pain management arrangements, postoperative monitoring, mobilisation, and follow-up, as clinically appropriate.

Patients considering a minimally invasive approach should discuss both its potential benefits and its limitations with their treating surgeon. No surgical technique is appropriate for every patient. However, possessing advanced skill in minimally invasive heart surgery permits the surgeon and referring cardiologist to customise the procedure, providing them with expanded treatment options.

WHAT CHANGES FOR PATIENTS

For suitable patients, minimally invasive cardiac surgery can provide access to the heart without a full midline incision or complete division of the breastbone. This difference in surgical access can affect how patients recover in the early postoperative period. The benefits and risks depend on the planned operation and the patient's health.

The practical differences and benefits for suitable patients include:

  • Smaller access incisions, often at the side of the chest, which may avoid a full median sternotomy for certain procedures.¹
  • When the breastbone is not divided, patients avoid the healing restrictions and specific wound complications associated with a full sternotomy.¹
  • The possibility of earlier mobilisation and resumption of some daily activities, subject to postoperative progress and the surgeon's advice.²
  • A shorter hospital stay has been demonstrated in randomised studies of selected minimally invasive mitral valve operations. This evidence cannot be applied to every cardiac procedure or individual patient.⁸,⁹
  • Potential differences in postoperative discomfort and incision-related complications, which vary by the operation, individual risk factors, and the surgical technique used.3

A smaller incision does not eliminate the major risks of heart surgery. It facilitates an overall easier and faster recovery experience and leaves back less trauma and scar.

ADDRESSING COMMON QUESTIONS ABOUT MICS

Does "keyhole" mean the operation is less thorough?

For many procedures, minimally invasive and conventional approaches may achieve the same treatment objective, such as repairing or replacing a heart valve. What differs is the route used to reach the heart and, in some cases, the operative technique. Suitability depends on the patient's condition.

Is minimally invasive cardiac surgery experimental?

Selected minimally invasive heart valve operations have been performed internationally since the 1990s and have been studied in clinical research. There is a vast body of evidence and as a result a growing trend towards minimally invasive procedures across the world, in advanced centers.

How can a surgeon see the heart valve through a smaller incision?

Depending on the surgical approach, an endoscope with high-definition or three-dimensional imaging may provide an enlarged view of the operative field.

Specialised instruments allow the surgeon to work through the chosen access route. The precise equipment and technique depend on the operation. In some cases, the heart positioning and access may even be better and more physiological, compared to open heart surgery. In other cases, the complexity of the procedure prohibits a minimally invasive route.

Is MICS available in Singapore?

Professor Kofidis established a prolific programme at the National University Health System (NUHS), which he has now brought to Mount Elizabeth Hospital, Orchard, offering the full spectrum of advanced cardiac care. His extensive work in this field has successfully popularised MICS, making it accessible for a wide variety of heart conditions both for Singaporeans and international patients. His pioneering work has been featured across medical journals, print media, television, and radio, aiming to educate the public in Singapore and the region about their modern treatment options. This renowned programme has also attracted numerous patients over the years, ensuring they no longer have to travel abroad to receive advanced, personalised minimally invasive treatments.

About Adjunct Professor Theodoros Kofidis

Professor Theodoros (Theo) Kofidis is a Singaporean cardiothoracic surgeon with more than 30 years of experience in adult cardiac surgery and an international reputation. He trained at leading global institutions, including Hannover Medical School, Strong Memorial Hospital, the Texas Heart Institute, Stanford University Medical School, and Zurich University Hospital. His clinical practice encompasses heart valve procedures—with a particular emphasis on valve repairs—coronary artery bypass surgery, and a wide range of adult cardiac operations utilising conventional and, where appropriate, minimally invasive approaches.

Before entering private practice, he served as Head of the Department of Cardiac, Thoracic and Vascular Surgery at the National University Heart Centre Singapore and as Group Chief of Cardiothoracic Surgery within the National University Health System.

He developed the centre's minimally invasive cardiac surgery programme, including single-incision approaches reported in medical publications.⁴

During his tenure at NUHCS, Adjunct Professor Kofidis also developed novel mitral valve repair techniques, as documented by the centre. Related approaches were described in peer-reviewed papers published in the European Journal of Cardio-Thoracic Surgery in 2023.¹⁰,¹¹,¹²

He is currently an Adjunct Professor of Surgery at the National University of Singapore. His professional work encompasses clinical research, surgical education, and the training and proctoring of surgical teams in minimally invasive techniques. He is a Fellow of both the Royal College of Surgeons of Edinburgh and the American Association for Thoracic Surgery, as well as the author-editor of Minimally Invasive Cardiac Surgery: A Practical Guide (CRC Press / Taylor & Francis, 2021). Outside of his clinical practice, he enjoys photography, aviation (holding a private pilot license), and reading. He is married to Persephone and is the proud father of a daughter, Danae.

About Theo Kofidis Cardiac Surgery

Theo Kofidis Cardiac Surgery provides specialist cardiac surgical consultations and the full spectrum of modern Heart Surgery at Mount Elizabeth Medical Centre, Orchard.

Address: 3 Mount Elizabeth, #11-06, Singapore 228510
Telephone: +65 6531 0788 Mobile/WhatsApp: +65 8399 6724 Website: https://cardiacsurgery.com.sg/
Instagram: https://www.instagram.com/proftheokofidis/ Facebook: https://www.facebook.com/proftheokofidis/

Download link for press release

Photos https://drive.google.com/drive/folders/1IyLMEvZHtF0CjEfFozxh3t8mCM3PcmyG
Press Release link https://drive.google.com/drive/folders/1Yjc7dlcStG6Dg_aw1TcS6f3qREHTTLj_
Photographs and captions are available for download and editorial use.

Selected clinical references for editors:

¹ Theo Kofidis Cardiac Surgery. Why Minimally Invasive Cardiac Surgery? [Internet]. Singapore: Theo Kofidis Cardiac Surgery; [cited 2026 Nov]. Available from: cardiacsurgery.com.sg

² Mount Elizabeth Hospitals. Meet Our People: (Adj) Prof Theodoros Kofidis, Cardiothoracic Surgeon [Internet]. Singapore: Mount Elizabeth Hospitals; [cited 2026 Nov]. Available from: mountelizabeth.com.sg/health-plus/article/cardiothoracic-surgeon-theodoros-kofidis

³ Kofidis T, Ong ZX, Wu D, Luo H, Chang G, Sazzad F, Sule JA, Hu P. Comparison of the safety and efficacy between minimally invasive cardiac surgery and median sternotomy in a low-risk mixed Asian population in Singapore. Singapore Med J. 2022;63(11):641-648. doi:10.11622/smedj.2021136. Available from: pmc.ncbi.nlm.nih.gov/articles/PMC9815174

⁴ Kofidis T, Chang G, Lee CN. Establishment of a minimally invasive cardiac surgery programme in
Singapore. Singapore Med J. 2017;58(10):576-579. doi:10.11622/smedj.2017022. Available from: pubmed.ncbi.nlm.nih.gov/28681054

⁵ Massetti M, et al. Video recording of cardiac surgical procedures: what the surgeon needs to know. J Cardiovasc Surg (Torino). 2008;49(5):691-4. pubmed.ncbi.nlm.nih.gov/18670389

⁶ Sidebotham DA, et al. Intraoperative transesophageal echocardiography for surgical repair of mitral regurgitation. J Am Soc Echocardiogr. 2014;27(4):345-66. pubmed.ncbi.nlm.nih.gov/24534653 

⁷ Gaudino M, et al. The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements. Circulation. 2021;144(14):1160-1171. pubmed.ncbi.nlm.nih.gov/34606302

⁸ Akowuah EF et al. Minithoracotomy vs Conventional Sternotomy for Mitral Valve Repair: A Randomized Clinical Trial. JAMA. 2023. https://pubmed.ncbi.nlm.nih.gov/37314276/

⁹ Amin A et al. Minimally invasive vs. conventional mitral valve surgery: a meta-analysis of randomised controlled trials. Front Cardiovasc Med. 2024. https://pubmed.ncbi.nlm.nih.gov/39188318/

¹⁰ NUHCS. A New Pathway in Mitral Valve Heart Surgery. https://www.nuhcs.com.sg/heart-information/pulse-magazines-articles/a-new-pathway-in-mitral-valve-heart-surgery

¹¹ Kofidis T. A mitral valve repair update: simple, intuitive and physiological techniques, using running sutures (part I). Eur J Cardiothorac Surg. 2023. https://pubmed.ncbi.nlm.nih.gov/36723443/

¹² Kofidis T. Mitral valve repair update: simple, intuitive and physiological techniques, using running sutures (part II). Eur J Cardiothorac Surg. 2023. https://pubmed.ncbi.nlm.nih.gov/36752526/

 

 

 

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

Professor Theo Kofidis Awarded Presidency of the World Society of Cardiovascular & Thoracic Surgeons for 2028 after securing Landmark Bid

  • Mahindra Last Mile Mobility is the winner of The Earthshot Prize 2026 in the 'Clean Our Air' category for its efforts to advance cleaner last-mile mobility while supporting drivers and small businesses
  • Founded by His Royal Highness Prince William, the prize money of £1 million has been awarded to Mahindra Last Mile Mobility to scale its innovative solutions and drive greater impact
  • Mahindra Last Mile Mobility has sold over 400,000 electric last-mile vehicles, helping avoid more than 185,000 metric tonnes of CO₂ emissions

MUMBAI, India, Nov. 20, 2026 /PRNewswire/ -- Mahindra Last Mile Mobility Limited (MLMML) has been named the winner of The Earthshot Prize 2026 in the 'Clean Our Air' category. MLMML is recognised for demonstrating how electric last-mile mobility can reduce emissions while creating economic opportunity. The award honours MLMML's efforts to accelerate the adoption of electric small commercial vehicles and make sustainable mobility accessible to drivers and small businesses across India.

MLMML has sold over 400,000 electric commercial vehicles in India, which have collectively travelled more than 9 billion kilometres and helped avoid approximately 185,000 metric tonnes of CO₂ emissions. MLMML's experience in India illustrates how a transition to electric vehicles can achieve meaningful scale when environmental benefits are combined with a strong economic case.  

MLMML will channel the £1 million Earthshot Prize grant into accelerating inclusive electric mobility—partnering with charities to train women drivers and enable access to affordable financing, working with cities to expand charging infrastructure into underserved areas, and collaborating with fellow Earthshot Finalists to take electric rickshaws to more communities. Our goal is to make clean mobility accessible to more people, while creating sustainable livelihoods at scale. 

Dr. Anish Shah, Group CEO and Managing Director, Mahindra Group, said, "Winning The Earthshot Prize is a tremendous honour and demonstration of what is possible when purpose is translated into action. We applaud Prince William's pioneering leadership in creating a platform that recognises and accelerates solutions for our planet. Since 1945, Mahindra has sought to enable others to rise and drive positive change in communities. We are proud of what Mahindra Last Mile Mobility has achieved in India to bring that purpose to life, and we are excited to build on this impact." 

Rajesh Jejurikar, Chairman, Mahindra Last Mile Mobility Ltd. and Executive Director & CEO – Auto & Farm Sector, Mahindra & Mahindra Ltd., said, "Last-mile mobility can deliver environmental and social impact at scale. Each of the 400,000 Mahindra electric vehicles is helping power 400,000 livelihoods every day. For many of these customers, these vehicles are working assets that support their families and enable micro-entrepreneurship. Being named as winner for The Earthshot Prize recognises a model where cleaner mobility, customer prosperity and scale can go together. It also strengthens our belief that solutions proven in India can have relevance across other markets." 

Suman Mishra, Managing Director & CEO, Mahindra Last Mile Mobility Limited, said, "We are deeply honoured by this recognition from The Earthshot Prize. It reinforces our belief that the fight against climate change must also improve everyday lives. Every electric vehicle on the road means cleaner air, lower emissions and better livelihoods for the millions who depend on last-mile mobility. By making electric mobility an economically compelling choice, we are demonstrating that environmental impact and economic progress can go hand in hand. This recognition inspires us to accelerate the transition to cleaner, more sustainable mobility at scale, across India and beyond."

MLMML becomes one of the few Indian companies to have won The Earthshot Prize, reinforcing the country's growing role in developing scalable climate solutions that combine sustainability, innovation and inclusive economic growth. 

About The Earthshot Prize 

Founded by HRH Prince William, The Earthshot Prize selects 15 Finalists each year across five areas: Protect and Restore Nature, Clean Our Air, Revive Our Oceans, Build a Waste-free World and Fix Our Climate. Five Winners are selected each year, with each receiving £1 million to help expand their solution. All 15 Finalists also join the year-long Earthshot Fellowship programme.  

About Mahindra 

Founded in 1945, the Mahindra Group is one of the largest multinational federations of companies, with 324,000 employees in more than 100 countries. It holds leadership positions in farm equipment, utility vehicles, information technology and financial services in India and is the world's largest tractor company by volume. The Group also has a strong presence in renewable energy, agriculture, logistics, hospitality and real estate.  

Learn more about Mahindra on https://www.mahindra.com/  

X and Facebook: @MahindraRise  

For updates subscribe to https://www.mahindra.com/newsroom/press-release

Media Contact Information
Swati Khandelwal 
Senior VP & Head, Group Communications, Mahindra Group
Email: khandelwal.swati@mahindra.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Mahindra Last Mile Mobility Wins The Earthshot Prize 2026 for Transforming Last-Mile Mobility in India

Mahindra Last Mile Mobility Wins The Earthshot Prize 2026 for Transforming Last-Mile Mobility in India

Recommended Articles